Literature DB >> 33711551

Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications.

Xian Zhou1, Ling Fu2, Pengli Wang3, Lan Yang3, Xiaoshu Zhu4, Chun Guang Li5.   

Abstract

Whilst the popular use of herbal medicine globally, it poses challenges in managing potential drug-herb interaction. There are two folds of the drug-herb interaction, a beneficial interaction that may improve therapeutic outcome and minimise the toxicity of drug desirably; by contrast, negative interaction may evoke unwanted clinical consequences, especially with drugs of narrow therapeutic index. Scutellaria baicalensis Georgi is one of the most popular medicinal plants used in Asian countries. It has been widely used for treating various diseases and conditions such as cancer, diabetes, inflammation, and oxidative stress. Studies on its extract and bioactive compounds have shown pharmacodynamic and pharmacokinetic interactions with a wide range of pharmaceutical drugs as evidenced by plenty of in vitro, in vivo and clinical studies. Notably, S. baicalensis and its bioactives including baicalein, baicalin and wogonin exhibited synergistic interactions with many pharmaceutical drugs to enhance their efficacy, reduce toxicity or overcome drug resistance to combat complex diseases such as cancer, diabetes and infectious diseases. On the other hand, S. baicalensis and its bioactives also affected the pharmacokinetic profile of many drugs in absorption, distribution, metabolism and elimination via the regulatory actions of the efflux pumps and cytochrome P450 enzymes. This review provides comprehensive references of the observed pharmacodynamic and pharmacokinetic drug interactions of Scutellaria baicalensis and its bioactives. We have elucidated the interaction with detailed mechanistic actions, identified the knowledge gaps for future research and potential clinical implications. Such knowledge is important for the practice of both conventional and complementary medicines, and it is essential to ensure the safe use of related herbal medicines. The review may be of great interest to practitioners, consumers, clinicians who require comprehensive information on the possible drug interactions with S. baicalensis and its bioactives.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  CYP; Cancer; Diabetes; Drug-herb interaction; P-gp; Scutellaria baicalensis Georgi

Year:  2021        PMID: 33711551     DOI: 10.1016/j.biopha.2021.111445

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  An Insight into Anticancer Effect of Propolis and Its Constituents: A Review of Molecular Mechanisms.

Authors:  Perumal Elumalai; Natarajan Muninathan; Sadhasivan T Megalatha; Arumugam Suresh; Kalimuthu Senthil Kumar; Nathan Jhansi; Kuppuswamy Kalaivani; Gunasekaran Krishnamoorthy
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-17       Impact factor: 2.650

Review 2.  An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.

Authors:  Sanowar Hossain; Muhammad Yousaf; Yang Liu; Dennis Chang; Xian Zhou
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

3.  Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil.

Authors:  Adriana Samide; Bogdan Tutunaru; Renata-Maria Varut; Bogdan Oprea; Simona Iordache
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-27

Review 4.  Synergistic Effects of Natural Product Combinations in Protecting the Endothelium Against Cardiovascular Risk Factors.

Authors:  Muhammad Yousaf; Valentina Razmovski-Naumovski; Muhammad Zubair; Dennis Chang; Xian Zhou
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

5.  The pharmacokinetic study on the interaction between nobiletin and anemarsaponin BII in vivo and in vitro.

Authors:  Jie Zhang; Meiling Fan; Xia Yu; Bin Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.